Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|25|2|205-208

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.25, Iss.2, 2018-02, pp. : 205-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

P152: Real‐world effectiveness of Ledipasvir/Sofosbuvir 8 weeks chronic hepatitis C treatment

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 95-96

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment of chronic hepatitis C with ground ledipasvir/sofosbuvir in a patient with Crohn's disease and short bowel syndrome

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 2, 2018-02 ,pp. : 214-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

O‐25: Ledipasvir/Sofosbuvir single tablet regimen is highly effective treatment for patients with HCV genotype 2 infection

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 15-15

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 12, 2015-12 ,pp. : 977-982

John Wiley & Sons Inc

Access to resources Recommend Favorite

O‐28: Safety and efficacy of ledipasvir/sofosbuvir for the treatment of hepatitis c infection: interim analysis of a prospective, observational study

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 17-17

John Wiley & Sons Inc

Access to resources Recommend Favorite